Side effects of tyrosine kinase inhibitors therapy in patients with non‑small cell lung cancer and associations with <i>EGFR</i> polymorphisms: A systematic review and meta‑analysis-Reference-Cited by-同舟云学术

Side effects of tyrosine kinase inhibitors therapy in patients with non‑small cell lung cancer and associations with EGFR polymorphisms: A systematic review and meta‑analysis

Published:2022-12-23 Issue:2 Volume:25 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Obradovic Jasmina¹,Todosijevic Jovana²,Jurisic Vladimir³

Affiliation:

1. Department of Sciences, Institute for Information Technologies, University of Kragujevac, 34000 Kragujevac, Republic of Serbia

2. Institute of Biology and Ecology, Faculty of Sciences, University of Kragujevac, 34000 Kragujevac, Republic of Serbia

3. Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Republic of Serbia

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference61 articles.

1. Cancer statistics;Siegel;CA Cancer J Clin,2021

2. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

3. Chemotherapy with cetuximab versus chemotherapy alone for chemotherapy-naive advanced non-small cell lung cancer;Yang;Cochrane Database Syst Rev,2014

4. Increased EGFR gene copy number detected by fluorescent in situ hybridization predicts outcome in non-small-cell lung cancer patients treated with cetuximab and chemotherapy;Hirsch;J Clin Oncol,2008

5. EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: Analysis of data from the phase 3 FLEX study;Pirker;Lancet Oncol,2012

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Toxicity Profile of eBAT, a Bispecific Ligand-Targeted Toxin Directed to EGFR and uPAR, in Mice and a Clinical Dog Model;Toxins;2024-08-26

2. PFN1 Knockdown Aggravates Mitophagy to Retard Lung Adenocarcinoma Initiation and M2 Macrophage Polarization;Molecular Biotechnology;2024-08-09

3. SIRT2 as a Potential Biomarker in Lung Adenocarcinoma: Implications for Immune Infiltration;Molecular Biotechnology;2024-06-20

4. Adenovirus pneumonia mimicking osimertinib‐induced pneumonitis in a patient with advanced NSCLC with EGFR mutation: A case report;Thoracic Cancer;2024-02-21

5. Contribution of immune cells in synergistic anti-tumor effect of ablation and immunotherapy;Translational Oncology;2024-02